Exane Derivatives Merck & Co., Inc. Put Options Transaction History

Exane Derivatives

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2018 Oct 24, 2018	BUY	$57.69 - $67.84 $17,307 - $20,352	300 Added 85.71%	650 $0
Q2 2018 Oct 24, 2018	SELL	$50.83 - $59.72 $12,707 - $14,930	-250 Reduced 41.67%	350 $0
Q2 2018 Jul 19, 2018	SELL	$50.83 - $59.72 $33,039 - $38,818	-650 Reduced 52.0%	600 $0
Q1 2018 Apr 30, 2018	BUY	$50.96 - $59.23 $63,700 - $74,037	1,250 New	1,250 $0

3,828

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $293B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.